MS Speaks

Multiple Sclerosis => TREATMENTS => Topic started by: agate on December 02, 2020, 03:35:02 pm

Title: MOVED: (Abst.) Safety and efficacy of oral ozanimod in RRMS: phase 2, RADIANCE study
Post by: agate on December 02, 2020, 03:35:02 pm

This topic has been moved to ZEPOSIA (ozanimod) (https://msspeaks.createaforum.com/index.php?board=40.0).

https://msspeaks.createaforum.com/index.php?topic=881.0